J
Juliette Randerson-Moor
Researcher at University of Leeds
Publications - 48
Citations - 3528
Juliette Randerson-Moor is an academic researcher from University of Leeds. The author has contributed to research in topics: Melanoma & CDKN2A. The author has an hindex of 30, co-authored 48 publications receiving 3196 citations. Previous affiliations of Juliette Randerson-Moor include St James's University Hospital.
Papers
More filters
Journal ArticleDOI
Genome-wide association study identifies three loci associated with melanoma risk.
D. Timothy Bishop,Florence Demenais,Mark M. Iles,Mark Harland,John C. Taylor,Eve Corda,Eve Corda,Juliette Randerson-Moor,Joanne F. Aitken,Marie-Françoise Avril,Esther Azizi,Bert Bakker,Giovanna Bianchi-Scarrà,Brigitte Bressac-de Paillerets,Donato Calista,Lisa A. Cannon-Albright,Thomas Chin-A-Woeng,Tadeusz Dębniak,Gilli Galore-Haskel,Paola Ghiorzo,Ivo Gut,Johan Hansson,Marko Hočevar,Veronica Höiom,John L. Hopper,Christian Ingvar,Peter A. Kanetsky,Richard F. Kefford,Maria Teresa Landi,Julie Lang,Jan Lubinski,Rona M. MacKie,Josep Malvehy,Graham J. Mann,Nicholas G. Martin,Grant W. Montgomery,Frans A. van Nieuwpoort,Srdjan Novaković,Håkan Olsson,Susana Puig,Marjan M. Weiss,Wilbert van Workum,Diana Zelenika,Kevin M. Brown,Alisa M. Goldstein,Elizabeth M. Gillanders,Anne Boland,Pilar Galan,David E. Elder,Nelleke A. Gruis,Nicholas K. Hayward,G. Mark Lathrop,G. Mark Lathrop,Jennifer H. Barrett,Julia A. Newton Bishop +54 more
TL;DR: Despite wide variation in allele frequency, these genetic variants show notable homogeneity of effect across populations of European ancestry living at different latitudes and show independent association to disease risk.
Journal ArticleDOI
A germline deletion of p14ARF but not CDKN2A in a melanoma–neural system tumour syndrome family
Juliette Randerson-Moor,Mark Harland,Sarah V. Williams,Darren Cuthbert-Heavens,Eamonn Sheridan,Joanne S. Aveyard,Kathryn Sibley,Linda Whitaker,Margaret A. Knowles,Julia A. Newton Bishop,D. Timothy Bishop +10 more
TL;DR: The results are consistent with either loss of p14(ARF) function being the critical abnormality associated with this syndrome, rather than contiguous loss of both the CDKN2A and CD KN2B genes as suggested previously; or disruption of expression of p16 by mechanisms as yet unknown.
Journal ArticleDOI
Serum 25-Hydroxyvitamin D3 Levels Are Associated With Breslow Thickness at Presentation and Survival From Melanoma
Julia Newton-Bishop,Samantha Beswick,Juliette Randerson-Moor,Yu-Mei Chang,Paul Affleck,Faye Elliott,May Chan,Susan Leake,Birute Karpavicius,Sue Haynes,Kairen Kukalizch,Linda Whitaker,Sharon Jackson,Edwina Gerry,Clarissa Nolan,Chandra Bertram,Jerry Marsden,David E. Elder,Jennifer H. Barrett,D. Timothy Bishop +19 more
TL;DR: Results from the retrospective study were consistent with a role for vitamin D in melanoma outcome, providing evidence that higher 25-hydroxyvitamin D levels, at diagnosis, are associated with both thinner tumors and better survival from melanoma, independent of Breslow thickness.
Journal ArticleDOI
Genome-wide association study identifies three new melanoma susceptibility loci
Jennifer H. Barrett,Mark M. Iles,Mark Harland,John C. Taylor,Joanne F. Aitken,Per Arne Andresen,Lars A. Akslen,Bruce K. Armstrong,Marie-Françoise Avril,Esther Azizi,Bert Bakker,Wilma Bergman,Giovanna Bianchi-Scarrà,Brigitte Bressac-de Paillerets,Brigitte Bressac-de Paillerets,Donato Calista,Lisa A. Cannon-Albright,Eve Corda,Anne E. Cust,Tadeusz Dȩbniak,David L. Duffy,Alison M. Dunning,Douglas F. Easton,Eitan Friedman,Pilar Galan,Paola Ghiorzo,Graham G. Giles,Graham G. Giles,Johan Hansson,Marko Hočevar,Veronica Höiom,John L. Hopper,Christian Ingvar,Bart Janssen,Mark A. Jenkins,Göran Jönsson,Richard F. Kefford,Giorgio Landi,Maria Teresa Landi,Julie Lang,Jan Lubinski,Rona M. MacKie,Josep Malvehy,Nicholas G. Martin,Anders Molven,Grant W. Montgomery,Frans A. van Nieuwpoort,Srdjan Novaković,Håkan Olsson,Lorenza Pastorino,Susana Puig,Joan Anton Puig-Butille,Juliette Randerson-Moor,Helen Snowden,Rainer Tuominen,Patricia Van Belle,Nienke van der Stoep,David C. Whiteman,Diana Zelenika,Jiali Han,Shenying Fang,Jeffrey E. Lee,Qingyi Wei,G. Mark Lathrop,Elizabeth M. Gillanders,Kevin M. Brown,Alisa M. Goldstein,Peter A. Kanetsky,Graham J. Mann,Stuart MacGregor,David E. Elder,Christopher I. Amos,Nicholas K. Hayward,Nelleke A. Gruis,Florence Demenais,Julia A. Newton Bishop,D. Timothy Bishop +76 more
TL;DR: Seven new regions with at least one SNP with P < 10−5 and further local imputed or genotyped support were selected for replication using two other genome-wide studies and showed no association with nevus or pigmentation phenotypes in a large British case-control series.
Journal ArticleDOI
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
Matthew Law,D. Timothy Bishop,Jeffrey E. Lee,Myriam Brossard,Nicholas G. Martin,Eric K. Moses,Fengju Song,Jennifer H. Barrett,Rajesh Kumar,Douglas F. Easton,Paul D.P. Pharoah,Anthony J. Swerdlow,Katerina P. Kypreou,John C. Taylor,Mark Harland,Juliette Randerson-Moor,Lars A. Akslen,Per Arne Andresen,Marie-Françoise Avril,Esther Azizi,Giovanna Bianchi Scarrà,Kevin M. Brown,Tadeusz Dębniak,David L. Duffy,David E. Elder,Shenying Fang,Eitan Friedman,Pilar Galan,Paola Ghiorzo,Elizabeth M. Gillanders,Alisa M. Goldstein,Nelleke A. Gruis,Johan Hansson,Per Helsing,Marko Hočevar,Veronica Höiom,Christian Ingvar,Peter A. Kanetsky,Wei V. Chen,Maria Teresa Landi,Julie Lang,G. Mark Lathrop,Jan Lubinski,Rona M. MacKie,Graham J. Mann,Anders Molven,Grant W. Montgomery,Srdjan Novaković,Håkan Olsson,Susana Puig,Joan Anton Puig-Butille,Abrar A. Qureshi,Graham L. Radford-Smith,Nienke van der Stoep,Remco van Doorn,David C. Whiteman,Jamie E Craig,Dirk Schadendorf,Lisa A. Simms,Kathryn P. Burdon,Dale R. Nyholt,Karen A. Pooley,Nick Orr,Alexander J. Stratigos,Anne E. Cust,Sarah V. Ward,Nicholas K. Hayward,Jiali Han,Hans Joachim Schulze,Alison M. Dunning,Julia A. Newton Bishop,Florence Demenais,Christopher I. Amos,Stuart MacGregor,Mark M. Iles +74 more
TL;DR: An international 2-stage meta-analysis of CMM genome-wide association studies (GWAS) combines 11 GWAS (5 previously unpublished) and a further three stage 2 data sets, totaling 15,990 CMM cases and 26,409 controls, finding five loci not previously associated with CMM risk reached genome- wide significance.